NBI components
The NASDAQ Biotechnology constituents can be found in the table below. Sort NBI stock components by various financial metrics and data such as performance, dividends, income statement and balance sheet.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AZNAstraZeneca PLCDR | 240.05 B USD | 77.18 USD | −0.55% | 3.607 M | 0.53 | 38.04 | 2.03 USD | +34.44% | 1.84% | Health Technology | Buy |
 AMGNAmgen Inc. | 166.375 B USD | 310.15 USD | −0.87% | 2.612 M | 0.73 | 44.35 | 6.99 USD | −52.48% | 2.79% | Health Technology | Buy |
 SNYSanofiDR | 127.945 B USD | 49.28 USD | +1.21% | 1.063 M | 0.47 | 21.21 | 2.32 USD | −20.45% | 2.79% | Commercial Services | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 109.1 B USD | 422.78 USD | +0.90% | 1.065 M | 0.90 | 27.43 | 15.41 USD | +22.79% | 0.00% | Health Technology | Buy |
 REGNRegeneron Pharmaceuticals, Inc. | 107.281 B USD | 973.80 USD | +0.60% | 351.356 K | 0.68 | 28.77 | 33.85 USD | −8.04% | 0.00% | Health Technology | Buy |
 GILDGilead Sciences, Inc. | 82.176 B USD | 65.96 USD | +2.14% | 8.733 M | 1.18 | 183.89 | 0.36 USD | −91.89% | 4.58% | Health Technology | Buy |
 MRNAModerna, Inc. | 44.958 B USD | 117.31 USD | −4.39% | 4.239 M | 1.03 | — | −15.68 USD | −235.29% | 0.00% | Health Technology | Buy |
 BIIBBiogen Inc. | 32.25 B USD | 221.50 USD | −0.56% | 655.151 K | 0.55 | 27.67 | 8.01 USD | −62.82% | 0.00% | Health Technology | Buy |
 ARGXargenx SEDR | 22.292 B USD | 374.63 USD | −2.07% | 369.022 K | 1.51 | — | −5.17 USD | +34.20% | 0.00% | Health Technology | Buy |
 BNTXBioNTech SEDR | 21.792 B USD | 91.67 USD | −0.42% | 389.88 K | 0.73 | 191.50 | 0.48 USD | −98.13% | 0.00% | Health Technology | Buy |
 ALNYAlnylam Pharmaceuticals, Inc. | 19.033 B USD | 150.47 USD | −0.59% | 322.795 K | 0.69 | — | −2.68 USD | +69.18% | 0.00% | Health Technology | Buy |
 GMABGenmab A/SDR | 19 B USD | 28.84 USD | +0.10% | 259.973 K | 0.42 | 23.91 | 1.21 USD | +8.61% | 0.00% | Health Technology | Buy |
 BGNEBeiGene, Ltd.DR | 18.084 B USD | 161.13 USD | −4.45% | 196.397 K | 0.99 | — | −7.57 USD | +59.27% | 0.00% | Health Technology | Strong buy |
 ILMNIllumina, Inc. | 17.607 B USD | 110.53 USD | −0.74% | 1.18 M | 0.65 | — | −8.15 USD | +71.48% | 0.00% | Health Technology | Neutral |
 RPRXRoyalty Pharma plc | 16.782 B USD | 28.09 USD | +0.43% | 2.88 M | 0.90 | 15.77 | 1.78 USD | +134.91% | 2.88% | Health Technology | Strong buy |
 BMRNBioMarin Pharmaceutical Inc. | 15.386 B USD | 81.03 USD | −0.84% | 1.521 M | 1.00 | 75.84 | 1.07 USD | +187.23% | 0.00% | Health Technology | Buy |
 NBIXNeurocrine Biosciences, Inc. | 13.757 B USD | 136.70 USD | −2.12% | 679.327 K | 0.88 | 37.58 | 3.64 USD | +497.14% | 0.00% | Health Technology | Buy |
 VTRSViatris Inc. | 13.288 B USD | 11.16 USD | −0.53% | 9.576 M | 1.05 | — | −0.05 USD | −103.19% | 4.30% | Health Technology | Neutral |
 SRPTSarepta Therapeutics, Inc. | 12.46 B USD | 131.82 USD | −0.36% | 735.589 K | 0.54 | 1982.26 | 0.07 USD | — | 0.00% | Health Technology | Strong buy |
 MEDPMedpace Holdings, Inc. | 12.089 B USD | 390.19 USD | −2.26% | 251.47 K | 1.12 | 39.75 | 9.82 USD | +24.38% | 0.00% | Commercial Services | Buy |
 INCYIncyte Corporation | 11.914 B USD | 53.06 USD | −0.82% | 1.505 M | 0.63 | 16.10 | 3.29 USD | +127.60% | 0.00% | Health Technology | Buy |
 UTHRUnited Therapeutics Corporation | 11.725 B USD | 264.27 USD | −0.67% | 391.702 K | 0.58 | 12.50 | 21.15 USD | +42.36% | 0.00% | Health Technology | Buy |
 ROIVRoivant Sciences Ltd. | 8.969 B USD | 11.13 USD | −1.07% | 2.57 M | 0.62 | 2.14 | 5.21 USD | — | 0.00% | Health Technology | Strong buy |
 LEGNLegend Biotech CorporationDR | 7.866 B USD | 43.24 USD | −5.01% | 887.591 K | 1.01 | — | −2.95 USD | −7.91% | 0.00% | Health Technology | Strong buy |
 ASNDAscendis Pharma A/SDR | 7.556 B USD | 133.46 USD | +0.25% | 218.271 K | 0.62 | — | −9.26 USD | +14.73% | 0.00% | Health Technology | Strong buy |
 PCVXVaxcyte, Inc. | 7.092 B USD | 65.19 USD | −0.58% | 533.487 K | 0.91 | — | −4.36 USD | −25.83% | 0.00% | Health Technology | Strong buy |
 JAZZJazz Pharmaceuticals plc | 6.911 B USD | 109.63 USD | −3.09% | 564.155 K | 0.76 | 23.85 | 4.60 USD | — | 0.00% | Health Technology | Buy |
 ITCIIntra-Cellular Therapies Inc. | 6.858 B USD | 64.96 USD | −0.92% | 730.757 K | 0.86 | — | −1.15 USD | +52.23% | 0.00% | Health Technology | Strong buy |
 BPMCBlueprint Medicines Corporation | 6.681 B USD | 106.70 USD | −1.51% | 406.715 K | 0.49 | — | −4.82 USD | +50.35% | 0.00% | Health Technology | Buy |
 CYTKCytokinetics, Incorporated | 6.494 B USD | 62.10 USD | −3.00% | 1.344 M | 1.09 | — | −5.40 USD | −17.98% | 0.00% | Health Technology | Strong buy |
 EXELExelixis, Inc. | 6.225 B USD | 21.37 USD | −1.79% | 1.688 M | 0.63 | 33.05 | 0.65 USD | +36.96% | 0.00% | Health Technology | Buy |
 RVMDRevolution Medicines, Inc. | 6.146 B USD | 37.25 USD | −0.53% | 1.013 M | 0.88 | — | −3.76 USD | −23.63% | 0.00% | Health Technology | Strong buy |
 GRFSGrifols, S.A.DR | 6.066 B USD | 7.00 USD | +0.86% | 521.629 K | 0.42 | 27.91 | 0.25 USD | −74.09% | 0.00% | Health Technology | Buy |
 IONSIonis Pharmaceuticals, Inc. | 5.704 B USD | 39.08 USD | −0.99% | 895.065 K | 0.88 | — | −2.67 USD | −15.53% | 0.00% | Health Technology | Buy |
 IBRXImmunityBio, Inc. | 5.616 B USD | 8.12 USD | +0.74% | 4.112 M | 0.22 | — | −1.05 USD | +0.05% | 0.00% | Health Technology | Buy |
 HALOHalozyme Therapeutics, Inc. | 5.492 B USD | 43.15 USD | −1.57% | 1.032 M | 0.96 | 17.85 | 2.42 USD | +85.23% | 0.00% | Health Technology | Strong buy |
 BBIOBridgeBio Pharma, Inc. | 5.445 B USD | 29.10 USD | +1.29% | 1.661 M | 1.33 | — | −3.23 USD | −13.87% | 0.00% | Health Technology | Strong buy |
 APLSApellis Pharmaceuticals, Inc. | 5.096 B USD | 41.99 USD | −1.25% | 979.77 K | 0.42 | — | −3.46 USD | +44.89% | 0.00% | Health Technology | Strong buy |
 ALPNAlpine Immune Sciences, Inc. | 4.455 B USD | 64.94 USD | +0.19% | 3.048 M | 1.83 | — | −0.69 USD | +59.41% | 0.00% | Health Technology | Neutral |
 KRYSKrystal Biotech, Inc. | 4.42 B USD | 154.76 USD | −2.50% | 193.259 K | 0.59 | 82.21 | 1.88 USD | — | 0.00% | Health Technology | Strong buy |
 MDGLMadrigal Pharmaceuticals, Inc. | 4.374 B USD | 205.25 USD | −0.81% | 234.068 K | 0.49 | — | −23.08 USD | −27.58% | 0.00% | Health Technology | Strong buy |
 CRSPCRISPR Therapeutics AG | 4.345 B USD | 51.17 USD | −4.44% | 1.634 M | 1.18 | — | −2.72 USD | +59.50% | 0.00% | Health Technology | Buy |
 IMVTImmunovant, Inc. | 4.27 B USD | 29.39 USD | −1.04% | 1.272 M | 1.31 | — | −1.83 USD | −10.48% | 0.00% | Health Technology | Strong buy |
 NUVLNuvalent, Inc. | 4.226 B USD | 65.48 USD | −3.02% | 445.545 K | 1.22 | — | −2.41 USD | −40.04% | 0.00% | Health Technology | Strong buy |
 ALKSAlkermes plc | 4.07 B USD | 24.05 USD | −0.87% | 1.002 M | 0.61 | 9.49 | 2.54 USD | — | 0.00% | Health Technology | Buy |
 HCMHUTCHMED (China) LimitedDR | 3.862 B USD | 21.75 USD | +4.47% | 316.285 K | 2.15 | 37.85 | 0.57 USD | — | 0.00% | Health Technology | Strong buy |
 INSMInsmed Incorporated | 3.859 B USD | 25.97 USD | −1.55% | 2.923 M | 1.86 | — | −5.24 USD | −22.78% | 0.00% | Health Technology | Strong buy |
 CRNXCrinetics Pharmaceuticals, Inc. | 3.785 B USD | 48.00 USD | −2.87% | 988.384 K | 1.20 | — | −3.77 USD | −15.15% | 0.00% | Health Technology | Strong buy |
 AXSMAxsome Therapeutics, Inc. | 3.443 B USD | 72.50 USD | −1.60% | 510.2 K | 0.78 | — | −6.38 USD | −67.92% | 0.00% | Health Technology | Strong buy |
 RAREUltragenyx Pharmaceutical Inc. | 3.4 B USD | 40.90 USD | −0.78% | 549.642 K | 0.65 | — | −8.03 USD | +21.74% | 0.00% | Health Technology | Strong buy |
 SMMTSummit Therapeutics Inc. | 3.264 B USD | 4.65 USD | −2.72% | 1.782 M | 0.68 | — | −0.17 USD | +90.98% | 0.00% | Health Technology | Strong buy |
 IDYAIDEAYA Biosciences, Inc. | 3.116 B USD | 41.17 USD | +1.30% | 446.904 K | 0.71 | — | −2.00 USD | −31.42% | 0.00% | Health Technology | Strong buy |
 IOVAIovance Biotherapeutics, Inc. | 3.068 B USD | 10.97 USD | −18.48% | 19.262 M | 4.43 | — | −1.82 USD | +24.46% | 0.00% | Health Technology | Strong buy |
 XENEXenon Pharmaceuticals Inc. | 3.06 B USD | 40.54 USD | −4.59% | 527.882 K | 1.72 | — | −2.71 USD | −16.58% | 0.00% | Health Technology | Strong buy |
 SWTXSpringWorks Therapeutics, Inc. | 3.029 B USD | 40.89 USD | −4.80% | 606.631 K | 0.52 | — | −4.99 USD | +3.03% | 0.00% | Health Technology | Strong buy |
 APGEApogee Therapeutics, Inc. | 3.002 B USD | 53.22 USD | +0.57% | 211.163 K | 0.77 | — | — | — | 0.00% | Health Technology | Strong buy |
 FTREFortrea Holdings Inc. | 2.952 B USD | 33.03 USD | −7.76% | 3.322 M | 4.23 | — | −0.04 USD | — | 0.00% | Commercial Services | Buy |
 IMCRImmunocore Holdings plcDR | 2.948 B USD | 58.95 USD | −1.50% | 335.562 K | 0.82 | — | −1.21 USD | −13.16% | 0.00% | Health Technology | Strong buy |
 ARWRArrowhead Pharmaceuticals, Inc. | 2.742 B USD | 22.08 USD | −10.68% | 2.54 M | 3.11 | — | −4.24 USD | −196.76% | 0.00% | Health Technology | Buy |
 GHGuardant Health, Inc. | 2.737 B USD | 22.37 USD | +15.07% | 5.869 M | 4.32 | — | −3.92 USD | +39.62% | 0.00% | Health Services | Strong buy |
 FOLDAmicus Therapeutics, Inc. | 2.734 B USD | 9.23 USD | −2.64% | 3.519 M | 1.30 | — | −0.50 USD | +30.03% | 0.00% | Health Technology | Buy |
 ACLXArcellx, Inc. | 2.661 B USD | 49.74 USD | −5.67% | 925.475 K | 2.33 | — | −1.06 USD | +75.18% | 0.00% | Health Technology | Strong buy |
 MRVIMaravai LifeSciences Holdings, Inc. | 2.633 B USD | 10.46 USD | +6.09% | 3.834 M | 1.83 | — | −0.99 USD | −186.08% | 0.00% | Health Technology | Buy |
 MRUSMerus N.V. | 2.613 B USD | 44.52 USD | −1.33% | 1.074 M | 1.58 | — | −2.72 USD | +17.30% | 0.00% | Health Technology | Strong buy |
 DNLIDenali Therapeutics Inc. | 2.611 B USD | 18.31 USD | −1.93% | 763.171 K | 0.66 | — | −0.97 USD | +66.23% | 0.00% | Health Technology | Strong buy |
 JANXJanux Therapeutics, Inc. | 2.537 B USD | 48.92 USD | −5.81% | 1.032 M | 1.00 | — | −1.22 USD | +24.13% | 0.00% | Health Technology | Strong buy |
 ACADACADIA Pharmaceuticals Inc. | 2.52 B USD | 15.25 USD | +0.26% | 2.31 M | 1.19 | — | −0.02 USD | +98.26% | 0.00% | Health Technology | Buy |
 RNAAvidity Biosciences, Inc. | 2.483 B USD | 25.96 USD | −4.21% | 1.163 M | 1.36 | — | −2.95 USD | +12.25% | 0.00% | Health Technology | Strong buy |
 PTCTPTC Therapeutics, Inc. | 2.473 B USD | 32.25 USD | +3.86% | 590.683 K | 0.57 | — | −7.69 USD | +2.63% | 0.00% | Health Technology | Neutral |
 TWSTTwist Bioscience Corporation | 2.467 B USD | 42.37 USD | −1.92% | 938.832 K | 0.61 | — | −3.35 USD | +11.09% | 0.00% | Health Technology | Buy |
 RYTMRhythm Pharmaceuticals, Inc. | 2.386 B USD | 39.14 USD | +1.66% | 371.714 K | 0.50 | — | −4.64 USD | −37.91% | 0.00% | Health Technology | Strong buy |
 NTLAIntellia Therapeutics, Inc. | 2.36 B USD | 24.46 USD | −1.61% | 2.043 M | 1.53 | — | −5.37 USD | +0.38% | 0.00% | Health Technology | Buy |
 VCELVericel Corporation | 2.338 B USD | 48.10 USD | −1.13% | 315.714 K | 0.79 | — | −0.01 USD | +98.56% | 0.00% | Health Technology | Strong buy |
 KYMRKymera Therapeutics, Inc. | 2.325 B USD | 37.90 USD | −1.84% | 333.731 K | 0.71 | — | −2.50 USD | +12.88% | 0.00% | Health Technology | Buy |
 MYGNMyriad Genetics, Inc. | 2.305 B USD | 25.47 USD | +0.87% | 1.135 M | 1.08 | — | −2.82 USD | −56.54% | 0.00% | Health Technology | Neutral |
 VERAVera Therapeutics, Inc. | 2.269 B USD | 41.32 USD | −2.39% | 947.081 K | 1.04 | — | −2.04 USD | +40.28% | 0.00% | Health Technology | Strong buy |
 GERNGeron Corporation | 2.254 B USD | 3.80 USD | −2.06% | 4.365 M | 0.40 | — | −0.35 USD | −0.29% | 0.00% | Health Technology | Strong buy |
 ARVNArvinas, Inc. | 2.151 B USD | 31.44 USD | −1.60% | 567.921 K | 0.81 | — | −5.93 USD | −4.89% | 0.00% | Health Technology | Strong buy |
 DYNDyne Therapeutics, Inc. | 2.109 B USD | 26.00 USD | +0.19% | 538.84 K | 0.72 | — | −3.97 USD | −18.88% | 0.00% | Health Technology | Strong buy |
 DCPHDeciphera Pharmaceuticals, Inc. | 2.085 B USD | 25.36 USD | −0.04% | 1.795 M | 0.25 | — | −2.21 USD | +5.92% | 0.00% | Health Technology | Neutral |
 AMPHAmphastar Pharmaceuticals, Inc. | 2.063 B USD | 42.21 USD | −0.52% | 595.849 K | 1.76 | 14.55 | 2.90 USD | +62.71% | 0.00% | Health Technology | Buy |
 RCKTRocket Pharmaceuticals, Inc. | 2.063 B USD | 22.72 USD | −2.61% | 401.938 K | 0.60 | — | −2.87 USD | +14.46% | 0.00% | Health Technology | Strong buy |
 ZLABZai Lab LimitedDR | 2.051 B USD | 20.08 USD | −4.43% | 1.891 M | 2.17 | — | −3.50 USD | +18.13% | 0.00% | Health Technology | Strong buy |
 RXRXRecursion Pharmaceuticals, Inc. | 2.043 B USD | 8.60 USD | −0.46% | 7.288 M | 1.91 | — | −1.60 USD | −16.02% | 0.00% | Health Technology | Buy |
 ADMAADMA Biologics Inc | 2.042 B USD | 8.81 USD | +27.13% | 11.7 M | 5.17 | — | −0.02 USD | +91.39% | 0.00% | Health Technology | Strong buy |
 KROSKeros Therapeutics, Inc. | 1.958 B USD | 54.27 USD | −5.78% | 379.03 K | 1.27 | — | −5.14 USD | −16.74% | 0.00% | Health Technology | Strong buy |
 GLPGGalapagos NVDR | 1.894 B USD | 28.55 USD | −0.76% | 75.533 K | 0.80 | — | −2.32 USD | −3035.40% | 0.00% | Health Technology | Neutral |
 AGIOAgios Pharmaceuticals, Inc. | 1.874 B USD | 33.00 USD | +0.24% | 506.066 K | 0.70 | — | −6.31 USD | −58.92% | 0.00% | Health Technology | Buy |
 SNDXSyndax Pharmaceuticals, Inc. | 1.848 B USD | 21.75 USD | −1.00% | 649.872 K | 0.67 | — | −3.22 USD | −33.10% | 0.00% | Health Technology | Strong buy |
 FUSNFusion Pharmaceuticals Inc. | 1.827 B USD | 21.48 USD | +0.47% | 383.838 K | 0.83 | — | −1.42 USD | +28.83% | 0.00% | Health Technology | Neutral |
 ARDXArdelyx, Inc. | 1.818 B USD | 7.77 USD | −3.60% | 5.051 M | 0.63 | — | −0.29 USD | +27.52% | 0.00% | Health Technology | Strong buy |
 INBXInhibrx, Inc. | 1.797 B USD | 34.29 USD | −1.15% | 506.507 K | 1.32 | — | −5.35 USD | −35.87% | 0.00% | Health Technology | Neutral |
 NVCRNovoCure Limited | 1.772 B USD | 16.47 USD | +2.11% | 821.779 K | 0.73 | — | −1.81 USD | −34.69% | 0.00% | Health Technology | Buy |
 BEAMBeam Therapeutics Inc. | 1.75 B USD | 21.26 USD | −5.68% | 1.367 M | 1.15 | — | −1.78 USD | +60.05% | 0.00% | Health Technology | Buy |
 EWTXEdgewise Therapeutics, Inc. | 1.712 B USD | 18.33 USD | −8.35% | 1.139 M | 1.50 | — | −1.54 USD | −15.47% | 0.00% | Health Technology | Strong buy |
 HRMYHarmony Biosciences Holdings, Inc. | 1.712 B USD | 30.14 USD | −3.64% | 250.707 K | 0.42 | 13.01 | 2.32 USD | −25.09% | 0.00% | Health Technology | Buy |
 SANASana Biotechnology, Inc. | 1.675 B USD | 7.56 USD | +0.80% | 3.845 M | 1.78 | — | −1.53 USD | +9.44% | 0.00% | Health Technology | Buy |
 GPCRStructure Therapeutics Inc.DR | 1.67 B USD | 35.82 USD | −7.32% | 603.506 K | 1.21 | — | −2.31 USD | — | 0.00% | Commercial Services | Strong buy |
 PTGXProtagonist Therapeutics, Inc. | 1.656 B USD | 28.23 USD | −0.14% | 513.289 K | 0.98 | 11.53 | 2.45 USD | — | 0.00% | Health Technology | Strong buy |
 VCYTVeracyte, Inc. | 1.634 B USD | 21.37 USD | +3.59% | 1.054 M | 1.57 | — | −0.93 USD | −122.18% | 0.00% | Health Technology | Buy |